-
Kenya's economy faces climate change risks: World Bank
-
France's largest wildfire in decades 'under control', says minister
-
South Korea baseball league cancels two games over heatwave
-
Warsaw and Kyiv exhume Volyn victims at centre of diplomatic quarrel
-
India PM Modi says he forgives protesters who abused him
-
California lifeguards wiped out from extreme weather
-
US plans steep water cuts for southwest amid Colorado River crisis
-
Amazon surges as US stocks shrug off bond yield worries
-
Oil giants report blowout profits on war, warn high gas prices could persist
-
Hungary to shut nuclear plant as heatwave hits central Europe
-
Google launches new satellite image AI tool, alarming researchers
-
Tech-fuelled rally fizzles as oil prices rise
-
US Fed dissenters call for rate hikes over sustained inflation
-
Alarm over climate-linked low level of German waterways
-
New York sues online prediction markets giant Kalshi
-
Commerzbank agrees to talks with UniCredit after two-year standoff
-
Profits surge at US oil giant amid Iran war supply shock
-
Fornaro Legal Releases Guidance to Help Businesses Maintain Clear Ownership Records During Growth
-
Stock markets rally on tech rebound
-
Japan probe made closest-ever asteroid flyby: space agency
-
France, Spain assess scorched terrain as new wildfires threaten other regions
-
British oil giant BP aims to sell North Sea business
-
Chipmaker Kioxia reports AI-driven 45-fold surge in quarterly net profit
-
China factory activity slides as leaders seek spending boost
-
Far right and far left battle for power in polarised Berlin
-
Tech rebound fuels record-breaking rally in South Korean stocks
-
The last trio: S.Africa's zoo elephants await their fate
-
Cables and cooling bring AI windfall to Indian suppliers
-
Oil industry sees war windfall but girds for political blowback
-
Anthropic's models gained unauthorized 'real-world' access during testing
-
Amazon beats expectations with cloud and AI growth
-
Apple tops estimates in CEO Cook's final quarter, but shares fall
-
Blowout Microsoft results lift US stocks as oil retreats
-
Milei demands expulsion of foreigners expressing 'hate' against Argentina
-
'Beginning of the end': Relief but no party as French wildfire winds down
-
Italy's Po River valley on drought alert
-
Southern Europe 'becoming more flammable' in hotter climate, experts say
-
Prada profits pinched as growth hard to chase
-
Mammoth bones found on parched bed of Danube in Bulgaria
-
Stocks climb on earnings and rates, oil retreats
-
MEXC Lists Grvt (GRVT) with $60,000 Worth of GRVT and 10,000 USDT in Airdrop+ Rewards
-
US economic growth slows in second quarter, missing expectations
-
George and Amal Clooney flee French home due to wildfire
-
Russia adds Telegram founder Durov to 'terrorist' blacklist
-
MEXC Ventures Supports Alpha Arena's APAC Debut at Coinfest Bali
-
Stocks diverge on earnings, as oil steadies
-
AI data centre supplier Zhongji InnoLight slips on Hong Kong debut
-
Eurozone economy grows despite Middle East war
-
May, June heatwaves caused 2,877 extra deaths in England: govt
-
Singapore group will develop 'most promising' Ebola vaccine
Norwegian effectively cured of HIV after transplant from brother
A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.
The patient's brother happened to carry a rare, virus-blocking genetic mutation.
The 63-year-old man, dubbed the "Oslo patient", is the latest in around 10 people worldwide who have gone into long-term remission from HIV after receiving a transplant to treat unrelated blood cancer.
The high-risk procedure normally requires a donor to have a specific mutation of their CCR5 gene, which blocks HIV from entering the body's cells.
Only around one percent of people in northern Europe have the necessary mutation.
The Oslo patient, who had been living with HIV since 2006, was diagnosed with a fatal blood cancer called myelodysplastic syndrome in 2017.
His doctors searched for a donor who would help treat both. When they couldn't find one, they chose the man's elder brother.
However, on the day of the transplant in 2020, the doctors were stunned to discover that the brother carried the CCR5 mutation.
"We had no idea... That was amazing," doctor Anders Eivind Myhre of the Oslo University Hospital told AFP.
- 'Winning the lottery twice' -
The patient said "it was like winning the lottery twice", added Myhre, who was also the lead author of a study describing the case in Nature Microbiology.
Two years after the transplant, the patient stopped taking the anti-retroviral drugs which had been reducing the level of HIV in his body.
The researchers found no trace of the virus in samples of the man's blood, gut and bone marrow.
"For all practical purposes, we are quite certain that he is cured," Myhre said.
Now the Oslo patient, whose name was not revealed, is "having a great time" and has more energy than he knows what to do with, Myhre said.
The painful and potentially dangerous transplant procedure is for people who have both HIV and deadly blood cancer so is not a feasible option for the millions of people living with the virus across the world.
However, researchers believe that studying these rare cases will reveal more about how HIV works in the hope of finding a cure for all patients.
- 'No longer a patient' -
The Oslo patient is the first person to receive a transplant from a family member.
The patient's immune system had been "completely replaced" by the donor's, sqaid study co-author Marius Troseid of the University of Oslo.
It was the first time this had been observed in a cured patient's bone marrow and gut, he told AFP.
Even before the researchers found out the brother had a CCR5 mutation, they had some hope that the Oslo patient's HIV could be cured.
That is because in 2024 it was revealed that the so-called "next Berlin patient" entered long-term remission despite receiving a transplant that did not have two copies of the mutated gene.
The original Berlin patient, Timothy Ray Brown, was the first person declared cured of HIV back in 2008. Patients in London, New York, Geneva, Duesseldorf and elsewhere followed.
Given the Oslo patient's robust health, Troseid suggested that his nickname was no longer suitable.
"The Oslo patient is perhaps no longer a patient. At least he doesn't feel like it," Troseid said.
J.Bondarev--CPN